Skip to main content
. 2021 Sep 6;10(3):CNS74. doi: 10.2217/cns-2021-0002

Table 4. . Survival data with methylation cutoff points of 21 and 9%.

  Patients (n) OS (months) PFS (months)
Cutoff point of 21%
Methylated 45 20.4 7.4
Unmethylated 64 13.3 6.8
Cutoff point of 9%
Methylated 56 18.5 7.1
Unmethylated 53 13.1 6.4

OS: Overall survival; PFS: Progression-free survival.